{
  "docId": "019de072-f015-70b3-a108-700a038da3d5",
  "docSlug": "ab0daada6947ab44927f267f74789e9c",
  "documentTitle": "Bionomics | Investor Presentation Deck | 16 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 16,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a checkmark/cross matrix to highlight the competitive advantage of BNC210.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-f015-70b3-a108-700a038da3d5/7",
  "deckHref": "/decks/019de072-f015-70b3-a108-700a038da3d5",
  "deckJsonHref": "/decks/019de072-f015-70b3-a108-700a038da3d5.json",
  "deckAnchorHref": "/decks/019de072-f015-70b3-a108-700a038da3d5#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.75,
        "x": 0.13,
        "y": 0.87
      },
      "kind": "disclaimer",
      "text": "* Potential benefits based on analysis of data from separate studies and not on results that might have been obtained from head-to-head studies. Includes Valium, Prozac, and other SSRIs/SNRIs.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe9ef6a8-894c-4118-8399-84bce72efb3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.96,
        "x": 0.02,
        "y": 0.238
      },
      "kind": "table",
      "text": "Comparison matrix of BNC210 vs SSRIs/SNRIs and BZDs across 6 criteria: Fast Onset, Not Sedating, No Withdrawal/Abuse, No Memory Impairment, No Motor Impairment, No Suicidal Ideation.",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43138eb5-a01e-42bb-a634-9f0076f7b09f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.85,
        "x": 0.07,
        "y": 0.03
      },
      "kind": "title",
      "text": "The Mechanism and Pharmacology of BNC210 Demonstrate its Advantages over Current Therapies for Anxiety Disorders and PTSD*",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b8baa09-299c-4ab4-8713-89081240274b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "b49d1bd1-06b3-46fb-9575-f44922cdd4ec",
      "evidence": "The slide uses a table to compare the product against competitors across specific features.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 6,
      "beatId": "acafe1ec-6fe8-4b25-ae9a-9112bd5c4e30",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate (Make it worse)",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The deck highlights the limitations of current therapies and the market size",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    },
    {
      "to": 7,
      "from": 7,
      "beatId": "113b37a2-a1bd-4e75-808a-f7dc3bc919e6",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Competition",
      "beatSlug": "sequoia-pitch-competition",
      "evidence": "The deck analyzes the competitive landscape",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "78fc056c-ae43-4691-bb01-042247be6fe2",
      "evidence": "The deck highlights the significant unmet need and market opportunity",
      "position": 0,
      "objective": "What is the cost of not addressing anxiety disorders and PTSD?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}